Free beta access. 5 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Vaccine development solves emerging diseases

PHRMA 22 [National Institute Health 4/?/2020 ; trade group representing companies in the pharmaceutical industry in the United States.; “New Era of Medicine: Vaccines,” https://www.phrma.org/science/new-era-of-medicine-vaccines]

Vaccines represent some of the most impactful public health advances seen to date, playing a critical role in reducing the spread of, and, in some cases, eliminating the threat of the world’s many devastating infectious diseases.

The human immune system is incredibly powerful and versatile, working continuously to keep a variety of invaders from causing infection and disease. From bacteria, to viruses, to parasites, the immune system recognizes invading threats and triggers a response in the body to contain and combat invaders. And although the immune system is incredibly robust, it is not invincible which is why vaccines are needed to help support the body’s defenses.

Vaccines present a number of unique challenges that make them particularly complicated to research, including scientific, clinical and logistical hurdles throughout the development process. These challenges are made more difficult during public health emergencies. Even with these challenges, some of the newer types of vaccines have the potential to move faster from initial virus identification to a viable vaccine, and faster from there to a licensing application and manufacturing scale up.

Sign in to recut, update, or save this card.